Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of “Moderate Buy” by Analysts

Chronological Source Flow
Back

AI Fusion Summary

Seven U.S. stocks receive mixed consensus ratings: Corvus, Arrowhead, AppFolio, Beachbody, CLEAR Secure, Vor Biopharma, and SiBone. Analysts range from sell to strong buy, with 12‑month targets from $9 to $263, and recent upgrades or downgrades noted.
#CONSENSUS_RECOMMENDATION #ANALYST_RATINGS #PRICE_TARGET #PHARMA #FINTECH #SECURE #BIOPHARMA
06/04 09:21 defenseworld.net
7 Πηγές

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of “Moderate Buy” by Analysts

Corvus Pharmaceuticalsmoderate buyprice targetOppenheimerBarclaysNASDAQ
06/04 09:38 defenseworld.net

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

POLITICSCOMPANIESECONOMYCONSENSUS RATING ARTICLES
06/04 09:38 defenseworld.net

AppFolio, Inc. (NASDAQ:APPF) Given Consensus Rating of “Buy” by Analysts

POLITICSCOMPANIESCONSENSUS RATING ARTICLES
06/04 09:58 defenseworld.net

CLEAR Secure, Inc. (NYSE:YOU) Given Consensus Recommendation of “Hold” by Brokerages

COMPANIESPOLITICSCONSENSUS RATING ARTICLES
06/04 09:58 defenseworld.net

The Beachbody Company, Inc. (NASDAQ:BODI) Given Average Rating of “Moderate Buy” by Brokerages

COMPANIESPOLITICSCONSENSUS RATING ARTICLES
06/04 09:58 defenseworld.net

Vor Biopharma Inc. (NASDAQ:VOR) Given Consensus Recommendation of “Moderate Buy” by Analysts

COMPANIESPOLITICSCONSENSUS RATING ARTICLES
06/04 11:28 defenseworld.net

SiBone (NASDAQ:SIBN) Given Average Recommendation of “Moderate Buy” by Analysts

POLITICSCOMPANIESCONSENSUS RATING ARTICLES
Comments
Loading...
0